SCHEMBL8525362

SCHEMBL8525362

Nc1ccc(Cc2n[nH]c(-c3ccccn3)nc2=O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
PKM P14618 2/20 0.47
ALPL P05186 1/20 0.47
ALOX15 P16050 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
BTK Q06187 1/20 0.47
KDM4E B2RXH2 2/20 0.42
PRMT5 O14744 2/20 0.41
F2 P00734 2/20 0.41
F12 P00748 2/20 0.41
PLAU P00749 1/20 0.41
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8523960 0.86 NPC1 (0.46) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8524721 0.83 L3MBTL1 (0.46) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8524927 0.78 NPC1 (0.50) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8525364 0.76 L3MBTL1 (0.44) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8525540 0.75 NPC1 (0.50) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8525157 0.74 LMNA (0.54) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL5789993 0.70 L3MBTL1 (0.66) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8524775 0.69 NPC1 (0.63) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL8525904 0.68 NPC1 (0.54) L3MBTL1NPC1RAB9ASMN1; SMN2PKM
SCHEMBL12955341 0.67 AR (0.77) PRMT5LMNAPARP1ENPP1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999007352-A2 METHOD FOR PROMOTING EXPRESSION OF LDL RECEPTOR GENE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-02-18 WO claimed
WO-1999007352-A2 METHOD FOR PROMOTING EXPRESSION OF LDL RECEPTOR GENE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-02-18 WO disclosed